ARKG Holdings of ATAI
ATAI Life Sciences
ATAI is a biopharmaceutical company focused on developing psychedelic and non-psychedelic compounds for the treatment of mental health disorders. The company generates revenue by advancing these therapeutic compounds through clinical trials and potentially bringing them to market through strategic partnerships and collaborations.
Trades of ATAI in ARKG
The ten most recent trades of ATAI Life Sciences in the ARKG ETF.View all trades
Date | Direction | Market Value | % of Position | % of ETF |
|---|---|---|---|---|
| Apr 03, 2023 | Sell | $220 | 100.00% | 0.00% |
| Mar 31, 2023 | Sell | $770 | 7.66% | 0.00% |
| Mar 30, 2023 | Sell | $8,309 | 91.09% | 0.00% |
| Mar 29, 2023 | Sell | $118,895 | 92.31% | 0.01% |
| Mar 28, 2023 | Sell | $1,725,335 | 93.61% | 0.09% |
| Mar 23, 2023 | Sell | $58,755 | 3.43% | 0.00% |
| Mar 21, 2023 | Sell | $17,274 | 0.99% | 0.00% |
| Mar 10, 2023 | Sell | $39,735 | 2.00% | 0.00% |
| Mar 09, 2023 | Sell | $10,606 | 0.51% | 0.00% |
| Mar 08, 2023 | Sell | $19,782 | 0.91% | 0.00% |